Related Experiment Video

Updated: Aug 4, 2026

Steady-state, Pre-steady-state, and Single-turnover Kinetic Measurement for DNA Glycosylase Activity
14:27

Steady-state, Pre-steady-state, and Single-turnover Kinetic Measurement for DNA Glycosylase Activity

Published on: August 19, 2013

O6-alkylguanine-DNA alkyltransferase inactivation in cancer chemotherapy

R S McElhinney1, T B H McMurry, G P Margison

  • 1University Chemical Laboratory, Trinity College, Dublin 2, Ireland. chemdept@tcd.ie

Mini Reviews in Medicinal Chemistry
|May 29, 2003
PubMed

Insights

O(6)-alkylguanine-DNA alkyltransferase repairs DNA damage, conferring drug resistance. Pseudosubstrate development inactivates this protein, showing promise for combination cancer therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • O(6)-alkylguanine-DNA alkyltransferase (MGMT) is a DNA repair protein.
  • MGMT confers cellular resistance to O(6)-guanine alkylating agents.
  • Understanding MGMT is crucial for cancer chemotherapy.

Purpose of the Study:

  • To review the chemical development of pseudosubstrates that inactivate MGMT.
  • To explore the relationship between pseudosubstrate structure and MGMT interaction.
  • To assess the clinical potential of combination therapy involving MGMT inactivation.

Main Methods:

  • Chemical synthesis and characterization of pseudosubstrates.
  • Biochemical assays to study enzyme-ligand interactions.
  • Structural biology investigations of protein-ligand complexes.

Main Results:

  • Pseudosubstrates effectively inactivate MGMT by targeting the active site cysteine.
  • Molecular structure of pseudosubstrates influences their binding affinity and inhibitory potency.
  • Combination therapy with alkylating agents and MGMT inactivators demonstrates significant anti-cancer potential.

Conclusions:

  • Pseudosubstrates are a promising strategy for overcoming MGMT-mediated drug resistance.
  • Targeting MGMT can enhance the efficacy of alkylating chemotherapy agents.
  • Further development of selective MGMT inactivators holds clinical promise for cancer treatment.

More Related Videos

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter12:15

Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter

Published on: May 29, 2019

Related Concept Videos

Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Base Excision Repair01:54

Base Excision Repair

One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...